quinazolines has been researched along with Dyslipidemia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariad, S; Geffen, DB; Geva, S; Lazarev, I | 1 |
| Chinetti-Gbaguidi, G; Colin, S; Kuivenhoven, JA; Staels, B | 1 |
| Joy, TR | 1 |
2 review(s) available for quinazolines and Dyslipidemia
| Article | Year |
|---|---|
Emerging small molecule drugs.
Topics: Animals; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Drug Design; Dyslipidemias; Humans; Hypolipidemic Agents; Liver X Receptors; Molecular Targeted Therapy; Orphan Nuclear Receptors; Peroxisome Proliferator-Activated Receptors; Quinazolines; Quinazolinones; Signal Transduction | 2015 |
Novel HDL-based therapeutic agents.
Topics: Animals; Apolipoprotein A-I; Biomarkers; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Humans; Hypolipidemic Agents; Molecular Mimicry; Quinazolines; Quinazolinones; Treatment Outcome | 2012 |
1 other study(ies) available for quinazolines and Dyslipidemia
| Article | Year |
|---|---|
Hypertriglyceridemia in patients with metastatic breast cancer and treatment with capecitabine.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine; Deoxycytidine; Diabetes Mellitus; Dyslipidemias; Female; Fluorouracil; Humans; Hypertriglyceridemia; Israel; Lapatinib; Middle Aged; Multivariate Analysis; Quinazolines; Regression Analysis; Retrospective Studies; Risk Factors | 2013 |